Bleeding Disorders (Von Willebrand disease, Hemophilia, and Immune-mediated Thrombocytopenia) in Dogs

Published on
Last updated on
5 min read

Key takeaways


Bleeding disorders in dogs affect the normal process of blood clotting.

  • The most common bleeding disorders in dogs are Von Willebrand disease, hemophilia A, and immune-mediated thrombocytopenia
  • Symptoms are rarely visible in healthy individuals, but may include prolonged bleeding, red or spotted gums, broken blood vessels on the skin, nose bleeds, blood in the urine, black stools, and bruising
  • Diagnostics consist of a physical examination and bloodwork
  • Treatment varies according to the specific bleeding disorder and might involve supportive care, blood or plasma transfusion, and medication
  • Prognosis varies depending on the specific form of bleeding disorder, response to treatment, and overall health of the individual
Are you concerned?

Connect with a vet to get more information about your pet’s health.

Book an online vet

A closer look: Bleeding Disorders (Von Willebrand disease, Hemophilia, and Immune-mediated Thrombocytopenia) in Dogs


Normal blood clotting, called hemostasis, involves blood vessels narrowing to slow blood flow and deployment of platelets and clotting proteins (or clotting factors) to mend breaks in the blood vessels, which occur due to injury.

Bleeding disorders affect the ability of the vessels to constrict properly, drastically reduce the number of platelets and factors, or impair platelets to adhere to the walls of damaged vessels.

Some conditions are rarer than others. The most common disorders are Von Willebrand disease (vWD), hemophilia A, and immune-mediated thrombocytopenia (IMT).

Some disorders cause major blood losses and can be considered emergencies. Immediate medical care is often necessary as blood and plasma transfusions are needed.

Symptoms that warrant emergency care include sudden lethargy, pale gums, and collapse. Prognosis often depends on the underlying cause, severity, and how long disease was occurring before detection.

Risk factors


Major episodes of blood loss due to a bleeding disorder might cause other symptoms such as lethargy, and collapse.

The risk of developing a bleeding disorder depends on the specific form. Von Willebrand disease and hemophilia A are congenital, meaning they are present at birth. Inheritable congenital diseases are more likely to develop in offspring of breeding pairs where one or both parents are carriers.

Immune-mediated thrombocytopenia has no known cause, so risk factors are difficult to identify.

Other forms of acquired bleeding disorders in dogs can develop following cancer, exposure to infectious agents, and certain drugs and vaccinations.

Possible causes


There are many potential causes of bleeding disorders. They can either be present at birth (congenital) or acquired later in life.

Von Willebrand disease (vWD) is the most common congenital bleeding disorder in dogs and results from a deficiency in the clotting factor called Von Willebrand factor. Another commonly known congenital bleeding disorder is hemophilia A; another clotting factor deficiency.

Other disorders such as immune-mediated thrombocytopenia (IMT) occur when the body’s immune system targets and destroys platelets. IMT is idiopathic, meaning the cause is unable to be determined.

Main symptoms


Bleeding disorders rarely present with outward symptoms in dogs.

Testing and diagnosis


Congenital bleeding disorders are often diagnosed in puppies after their first surgical intervention, such as spaying/neutering, as the bleeding during and following surgery is excessive and does not stop naturally.

In other cases, the diagnostic process begins with a thorough physical examination and medical history of the patient.

Bloodwork is used to test for the number of platelets and the ability of the blood to clot.

Additional testing includes the examination of a bone marrow sample and genetic screening tests.

Steps to Recovery


Treatment largely depends on the specific bleeding disorder.

IMT can be treated with:

  • Steroids
  • Chemotherapy
  • Blood or plasma transfusions
  • Supportive care such as crate rest and exercise restriction

In cases of vWD, dogs sometimes respond well to a drug called desmopressin acetate which might increase the level of vW factors. In an emergency situation blood or plasma transfusions are necessary to stabilize the patient.

The prognosis varies according to the specific bleeding disorder.

Dogs affected with IMT have a good to guarded prognosis. 80% of patients respond well to treatment and make a full recovery with a possibility of relapse. 20% are either euthanized or die as a consequence of the disease.

For vWD, there is no known definitive treatment, and dogs that are stabilized when an injury occurs usually have a positive outcome.

Prevention


Bleeding disorders are not contagious. Most conditions, including vWD and IMT, are either congenital or idiopathic and the only form of prevention is not breeding affected dogs.

Certain types of drugs and vaccines have been associated with some acquired bleeding disorders. Close monitoring of patients following vaccination and during treatments is advised.

Are Bleeding Disorders (Von Willebrand disease, Hemophilia, and Immune-mediated Thrombocytopenia) in Dogs common?


Some bleeding disorders in dogs are much more common than others. The most common bleeding disorders in dogs are vWD and IMT.

Typical Treatment


  • Steroids
  • Supportive care
  • Blood and plasma transfusion
  • Medications
  • Chemotherapy

References


Bleeding Disorders of Dogs
Susan M. Cotter , DVM, DACVIM - Writing for Merck Veterinary Manual
Von Willebrand's Disease in Dogs
Krista Williams, BSc, DVM; Ernest Ward, DVM - Writing for VCA Animal Hospitals
Immune-Mediated Thrombocytopenia
Eileen Donoghue - Writing for Veterinary Health Center University of Missouri
Hemophilia A
No Author - Writing for Cornell University College of Veterinary Medicine

Our editorial committee

Our medical review team is responsible for validating and maintaining the quality of our medical information.